| 5CSX: reference: A Novel RAF Kinase Inhibitor with DFG-Out-Binding Mode: High Efficacy in BRAF-Mutant Tumor Xenograft Models in the Absence of Normal Tissue Hyperproliferation., Waizenegger IC, Baum A, Steurer S, Stadtmuller H, Bader G, Schaaf O, Garin-Chesa P, Schlattl A, Schweifer N, Haslinger C, Colbatzky F, Mousa S, Kalkuhl A, Kraut N, Adolf GR, Mol Cancer Ther. 2016 Mar;15(3):354-65. doi: 10.1158/1535-7163.MCT-15-0617. Epub , 2016 Feb 25. PMID: 26916115 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).